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a  b  s  t  r  a  c  t
The  Sox  transcription  factor family  consists  of  20  members  in  the  human  genome.  Many  of them  are
key  determinants  of  cellular  identities  and  possess  the  capacity  to reprogram  cell fates  by pioneering  the
epigenetic  remodeling  of  the  genome.  This  activity  is intimately  tied  to  their  ability  to  speciﬁcally  bind  and
bend DNA  alone  or with  other  proteins.  Here  we discuss  our  current  knowledge  on  how  Sox  transcription
factors  such  as  Sox2,  Sox17,  Sox18  and  Sox9 ‘read’  the  genome  to  ﬁnd  and  regulate  their  target  genes  andeywords:
ox
ranscription factors
ene regulation
NA binding
highlight  the  roles  of partner  factors  including  Pax6, Nanog,  Oct4  and  Brn2.  We  integrate  insights  from
structural  and  biochemical  studies  as  well  as high-throughput  assays  to  probe  DNA  speciﬁcity  in vitro  as
well  as in  cells and tissues.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd.  This  is  an open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ellular reprogramming
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. Introduction
Transcription factor (TF) proteins determine cellular identi-
ies and direct embryonic development by selectively binding to
enomic DNA to orchestrate gene expression programs. Amongst
he ∼21,000 human protein-coding genes about 1600 encode for
equence-speciﬁc DNA binding TF proteins [1,2]. Most TFs belong to
ene families comprising a handful up to several hundred members
n mammalian genomes. Members of such gene families are termed
aralogs and evolved by the expansion of ancestral genes through
ene or genome duplications [3]. The gene encoding for the TF Sry
sex-determining region Y) was discovered following an intense
earch for the testis-determining factor on the Y-chromosome [4,5].
he sequence conservation between mouse and human Sry genes
s restricted to a region of 79 amino acids. This sequence motif
ncodes for a special version of the high-mobility group (HMG) box
lso found in a class of ubiquitous and highly abundant non-histone
NA binding proteins [6]. In the original Sry study, four more
omologous genes were isolated from autosomal loci of mouse 8.5
.p.c. (days post coitum) cDNA libraries corresponding to Sox1-4
4,7]. The unifying feature of these genes is the Sry-like HMG box;
ence this gene family was  termed Sox. Additional members were
ubsequently detected and cloned in a wide array of tissues taking
dvantage of sequence signatures within the HMG  box [7–10]. With
he availability of whole genome sequences it became clear that the
ouse and human genomes each encodes for 20 Sox genes [11].
ased on the sequence identity of the HMG  box, the Sox genes are
lassiﬁed into 8 groups denoted SoxA to SoxH with 1–3 members
ach [12].
The Sox TFs were soon found to constitute essential molecules
ith key roles during virtually all phases of embryonic develop-
ent and the fate determination of many cell types as summarized
n a number of excellent reviews [13–23]. The prominence of the
ene family received a further elevation when one of its members,
ox2, was found to be a core component of TF cocktails with the
bility of converting mouse and human somatic cells to induced
luripotent stem cells (iPSCs) [24–26]. Most Sox TFs are highly
leiotropic as they bind and regulate different gene sets in dif-
erent cellular contexts. Sox2, for example, acts in a staggeringly
iverse array of cell and tissue types including pluripotent stem
ells, neural lineages, lung tissue, the eye and the ear [27]. Yet, what
ndows Sox proteins with this versatility and developmental plas-
icity largely remains elusive. Moreover, Sox proteins are reported
o function as ‘pioneer’ factors. That is, they are able to bind com-
act transcriptionally silent chromatin and to recruit non-pioneer
Fs to drive cell fate conversions. In this review, we  discuss recent
rogress in the understanding of the biochemical basis for DNA and
hromatin recognition by Sox proteins, mechanisms for the part-
ership of Sox proteins with other TFs and mechanisms for their
ioneering activity.
. Principles of DNA recognition
.1. Structural basis
Evidence that the Sox HMG  box enables DNA binding was ﬁrst
rovided for the SRY protein. Binding was found to be sequence
peciﬁc with a preference for a C1T2T3T4G5T6 C7-like motif [28,29].
his core-motif was later veriﬁed to be the preferred binding
equence for all 20 Sox proteins although there can be subtle vari-
tions especially in the ﬂanks of the element and a substantialPlease cite this article in press as: L. Hou, et al., Molecular basis for the 
http://dx.doi.org/10.1016/j.semcdb.2016.08.005
egeneracy is tolerated [30,31]. As several sex-reversing mutations
f SRY profoundly reduced the afﬁnity for DNA, it was  immediately
lear that DNA binding is of critical functional importance [28].
he ﬁrst structural view on the DNA recognition by Sox TFs was PRESS
ental Biology xxx (2016) xxx–xxx
provided by the group of Marius Clore with the nuclear magnetic
resonance (NMR) structure of the HMG  box of human SRY bound
to a G1T2T3T4G5T6G7C dsDNA in 1995 [32]. In the same year, the
NMR structure of the HMG  box of the related Lef-1 protein bound to
CACCC1T2T3T4A5A6GCTC was reported [33]. More recently, crystal
structures of Sox2 [34], Sox17 [35], Sox4 [36] and Sox18 [37] bound
to cognate DNA elements were published and a Sox9/DNA complex
was deposited to the protein data bank (PDB-id 4S2Q). Altogether,
these studies provided valuable insights into the molecular basis
for the DNA recognition by Sox proteins. The HMG  box folds into an
L-shaped ‘boomerang’ structure constructed of three alpha helices
and extended N- and C-terminal tails with an irregular strand-like
conﬁguration (Fig. 1A, B). Two hydrophobic clusters stabilize the
fold, which include a conserved set of aromatic amino acids such
as Phe10, Trp13 and Trp41 and Phe52 (HMG numbering according
to reference [12] used throughout this manuscript). The short and
long arms of the ‘L’ have also been denoted as major and minor
‘wings’ [38–40]. The shorter major wing encompasses the bulk of
the amino acids and is composed of helices 1, 2 and the N-terminal
turn of helix 3. The minor wing consists of the remainder of helix 3
and the extended N-terminus, which packs against helix 3. Contrary
to most other TFs that bind to the major groove of the DNA, the Sox
HMG binds to the minor groove of the DNA and its binding induces
an overall bend of 60−70◦ (Fig. 1C). All base pairs of the CATTGT core
motif are directly contacted by amino acids via base-speciﬁc inter-
actions (Fig. 1D, E). Several of the contact residues emanate from
the R5PMNAF10MVW  Sox signature motif at the N-terminus of the
HMG  box. The F10M11 dipeptide constitutes a wedge that interca-
lates between the central T3A3 ′T4A4 ′ base pair forcing the kinking of
the DNA. Notably, all residues engaged in base-speciﬁc DNA inter-
actions are invariant amongst the 20 Sox TFs (Fig. 1E). Only some
residues mediating non-speciﬁc interactions with the DNA back-
bone show conservative replacements such as residues 2 and 15.
Overall, the highly positively charged DNA binding surface exhibits
a strong evolutionary conservation, whereas interfaces pointing
away from the DNA are variable amongst Sox TFs (Fig. 1F, G). There-
fore, monomeric forms of all 20 Sox TFs are expected to bind DNA in
an identical fashion. Nevertheless, with the availability of a grow-
ing number of structures some variations at the Sox/DNA interface
have been observed. For example, Arg18 and Asn30 can undergo a
concerted conformational switch [36]. Moreover, Arg5, His29 and
Tyr72 can structurally re-orient to better accommodate changes
in the sequence of the DNA binding element [37]. However, these
changes are dictated by the chemical environment provided by the
DNA sequence and do not reﬂect differences inherent to individual
Sox TFs. Thus, other mechanisms must account for the multitude
of non-redundant and cell-type speciﬁc functions of Sox TFs.
2.2. Differences between Sox TFs and other HMG  box proteins
Sox TFs belong to the HMG  box superfamily of proteins, which is
evolutionarily ancient with members present in unicellular eukary-
otes such as yeast species. The HMG  superfamily can be broadly
divided into two groups based on the mechanism of DNA interac-
tion [41,42]. First, there are sequence speciﬁc HMG boxes (ssHMGs)
including the Sox TFs, the Tcf/Lef TFs and the yeast mating pro-
tein MATA. Second, there are the non-sequence speciﬁc HMG  boxes
(nsHMG) including HMG1, HMG2, the SSRP1 subunit of FACT (facil-
itates chromatin transcription), the mitochondrial TFAM/mtTF1
and UBF1 [41,42]. It appears plausible that sequence speciﬁcity
evolved after the divergence of ssHMG and nsHMG groups however
this question is not ultimately resolved. In an alternative scenario,genome engagement by Sox proteins, Semin Cell Dev Biol (2016),
nsHMGs lost sequence speciﬁcity while sequence speciﬁcity was
present in the ancestral protein.
Lef-1 of the Tcf/Lef family exhibits a similar fold and DNA binding
mechanism as Sox proteins but has a number of features distin-
ARTICLE IN PRESSG ModelYSCDB-2106; No. of Pages 11
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Fig. 1. DNA recognition by the Sox HMG  box.
(A) Topological model of the Sox HMG  (blue) bound to DNA (gray) shown as semi-transparent surface and ribbons. Helices a1–a3, N-and C-termini and the postion of the
CATTGT core element are marked. (B) The DNA bases and the DNA contact amino acids are shown as ball-and-sticks.
(C)  Ideal B-DNA is superimposed onto DNA when bound to the Sox HMG  and the bending angle is highlighted. (D) A sequence logo of a Sox motif aligned with the cognate
sequence of the Prox1 gene. (E) Sequence logo constructed using the HMG  box sequences of the 20 mouse Sox proteins. The residues involved in DNA binding are marked with
spheres and the nucleotides they bind are indicated using the numbering scheme in (D). The apostrophe denotes nucleotides of the reverse strand. (F) Conservation scores
o ht gre
s  to Pro
s ra/).
g
s
A
t
6
N
t
gf  the 20 mouse Sox paralogs were mapped to the surface of the HMG  box with lig
urface representation of the Sox18 HMG. Structural coordinates of SOX18 bound
oftware was  used to generate structural cartoons (http://www.cgl.ucsf.edu/chime
uishing it from Sox TFs [33,35]. First, a number of invariant Sox
ignature DNA contact residues are replaced in this family including
sn30, Ser34 and Tyr72 (Fig. 1E). These differences lead to varia-
ions in the consensus binding sequence in particular at position
 (CTTTGA6A for Lef-1 versus CTTTGT6C for Sox) [30,43]. Next, thePlease cite this article in press as: L. Hou, et al., Molecular basis for the 
http://dx.doi.org/10.1016/j.semcdb.2016.08.005
MR structure of a Lef-1/DNA complex revealed an extended C-
erminal tail that crosses over to make contacts with the major
roove accompanied by a tilting of helix 3 in comparison to the Sryen indicating low conservation and dark green high conservation. (G)  Electrostatic
x1 DNA were used in all structural panels ([37]; PDB ID: 4Y60) and the Chimera
helix 3 [33,40]. The non-conservative replacement of Tyr72 in the
Sox HMG  by Ala72 in the Lef-1 HMG  could be causative for this dif-
ference. In the case of the Sox HMG, Tyr72 interacts with the base
pair at position 6 and positions the C-terminal tail ﬁrmly within
the minor groove and likely prevents ﬂipping over into the majorgenome engagement by Sox proteins, Semin Cell Dev Biol (2016),
groove [44].
nsHMG proteins HMG1 and HMG2 are highly abundant struc-
tural components of nuclear chromatin [6] and TFAM organizes the
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itochondrial genome [45,46]. Whereas all Sox genes encode only
 single HMG  box, certain nsHMGs such as HMG1 & HMG2 and
FAM possess tandem repeats of this domain [47,48]. A series of
tructures of free and DNA bound nsHMGs could clarify some key
ifferences between sequence-speciﬁc and non-sequence speciﬁc
NA recognition by HMG boxes [39,45,46,49–53]. While the over-
ll L-shaped and triple-helical fold is very similar for both nsHMG
nd ssHMGs, all nsHMGs contain two rather than one non-polar
ntercalation sites. The position corresponding to the secondary
ntercalation site corresponds to the polar Asn30 involved in base-
peciﬁc contacts in the Sox HMG  (Fig. 1B, E). A number of other
ox signature sequences mediating speciﬁc DNA binding are either
bsent or poorly conserved within the nsHMG group including
sn8, Ser34 and Tyr72 [51]. In sum, while the overall fold is similar
or nsHMG and ssHMG boxes, the mechanism of DNA binding is
rofoundly different.
.3. DNA bending
Circular permutations assays provided ﬁrst evidence that Sox
Fs, like nsHMG boxes, bend DNA [54,55]. Structural analysis
evealed that the shape complementarity between the concave
ace of the L-shaped HMG  box and intercalation of apolar residues
acilitate DNA bending, minor groove widening and helical unwind-
ng [32,33]. As the DNA bending activity of many nsHMGs is
roposed to inﬂuence nuclear compartmentalization and chro-
atin remodeling, it is intriguing to speculate that Sox TFs are
ore determinants of the 3D-architectures of cell-type speciﬁc
nhanceosomes. Indeed, the degree of DNA bending was reported
o be critical for the transcriptional output of Sox2 [56]. Likewise,
ex-reversing mutations of human SRY were reported to decrease
he overall bending angle of SRY-bound DNA [44]. In agreement
ith this, FRET studies suggested that the bending angle depends
n three critical factors: (i) the amino acid composition of the HMG
ox (i.e. Sry, Sox5, Lef-1), (ii) the sequences of the DNA element and
iii) at least for Lef-1 on the length of the C-terminal tail [57,58].
owever, a detailed comparison of the structures of DNA elements
ound to Sox2, Sox9, Sox17, Sox4 and Sox18 indicated very similar
ending angles of the DNA duplex ranging from 60◦ to 70◦ [37]. Fur-
her, the DNA deformation at the level of base-pair parameters such
s the twist angle describing the local unwinding and the roll angle
escribing the local opening of the base-pairs is also very similar
or all ﬁve Sox HMG/DNA structures. Therefore, currently there is
o evidence that the 20 Sox factors exhibit differential DNA bend-
ng activity and that speciﬁc bends explain the cell type speciﬁc
ctivity of Sox TFs. Yet, the precise DNA sequence requirement and
ffects of mutations within the HMG  box on bending should be
ore rigorously assessed.
.4. Dynamics of the HMG  box
A number of HMG box structures were analyzed as apo-proteins
n the absence of DNA providing insights into the dynamics of
he domain and structural adjustments accompanying DNA bind-
ng [38,39,50,53,59–61]. Both, DNA and the HMG box undergo
utually induced structural changes as the HMG  is subjected to
 pronounced disorder to order transitions (reviewed in reference
40]). Even at low temperatures HMG  boxes are partially unfolded
33,38]. Major and minor wings are tied together by structurally
ndependent hydrophobic cores leading to strong movements of
he wings relative to each other. In the DNA-bound Sox17 HMG
omain, helix 3 ﬂips ∼5◦ away from the DNA as compared toPlease cite this article in press as: L. Hou, et al., Molecular basis for the 
http://dx.doi.org/10.1016/j.semcdb.2016.08.005
 superimposed apo-protein [35]. Further, the C-terminal tail is
ighly disordered in the apo-form but latches into the minor groove
pon DNA recognition and adopts an ordered conformation. In sum,
he HMG  box is very dynamic and DNA binding leads to a recipro- PRESS
ental Biology xxx (2016) xxx–xxx
cal induced ﬁt. Interestingly and counter-intuitively, deforming the
DNA is energetically inexpensive and thought to be driven by favor-
able entropic contributions caused by the displacements of ordered
waters from the minor groove [57,58].
3. Impact of partner factors on DNA recognition
The context dependent function of Sox TFs is driven by a ‘Sox
partner code’, that is, the dynamic association of Sox TFs with part-
ner proteins in a cell type speciﬁc fashion. The partner switches
change genome engagement, gene expression programs and the
developmental trajectories driven by Sox TFs. The partnering of Sox
TFs has been covered in a number of excellent reviews [23,62,63].
Here we will focus on more recent insights on the molecular basis
for these interactions and their functional consequences.
3.1. Homotypic interactions
While the majority of Sox TFs form monomers in solution, SoxD
proteins (Sox5, Sox6 and Sox13) are an exception, as they possess
a group-speciﬁc N-terminal coiled-coil domain that mediates DNA
independent homo and SoxD heterodimerization [64]. Sox5 exists
in short and long isoforms where the short isoform lacks the coiled-
coil domain [65]. Dimerization of SoxD TFs facilitates binding to
clustered Sox elements with little constraints on half-site spacing
and a high tolerance for degeneracy in the binding site [65,66]. A
Sox6 ChIPseq study reinforced this notion as single Sox motifs and
a long A-rich sequence were identiﬁed rather than a distinctive
dimer motif [67].
SoxE proteins (Sox8, Sox9, Sox10) encode a unique 40 amino
acids dimerization (DIM) domain N-terminally preceding the HMG
box [68–70]. SoxE TFs dimerize in a highly cooperative fashion
but only in the presence of a GACAATGnnnnC1A2T3T4G5T6C7-like
palindromic DNA binding sequence (Fig. 2A). Thus, in contrast to
the constitutive SoxD dimers, SoxE dimerization is DNA depen-
dent. Different from other dimerizing TFs that favor composite DNA
elements with ﬁxed spacing [71], SoxE factors are able to accom-
modate a range of ﬂexibly spaced half-sites [72]. All three SoxE
proteins can also effectively heterodimerize with each other but
do not dimerize with non-SoxE proteins. Interestingly, truncated
DIM-SoxE constructs can also effectively dimerize with isolated
SoxE HMG  boxes, suggesting that a single DIM is necessary and suf-
ﬁcient for dimer formation (Fig. 2A). Therefore, the dimerization
must be driven by DIM-HMG rather than by DIM–DIM interac-
tions and both, the SoxE DIM and the SoxE HMG  contain structural
elements facilitating it [72].
Surprisingly, Sox2 from the SoxB1 group has recently been
reported to exist in both monomeric and dimeric forms in human
neutrophils [73]. Truncation analysis revealed that the group B
homolog (GBH) domain C-terminally of the HMG  box is required for
the homodimerizatin of Sox2. Triggered by the presence of bacterial
DNA, Sox2 homodimers, but not the monomers, activate the TAB2-
TAK1 complex leading to the stimulation of the innate immune
response [73]. Therefore, homotypic Sox interactions, dependent
or independent of DNA, could be of more functional importance
than previously assumed.
3.2. Heterotypic interactions
3.2.1. Sox/Pax
Sox2 has been identiﬁed to bind and regulate the expression
of the -crystallin gene in the chicken eye cooperatively withgenome engagement by Sox proteins, Semin Cell Dev Biol (2016),
Pax6 on a regulatory element termed DC5 [74,75]. DC5 expression
requires precise and compact spacing between the Sox and Pax
half-sites [75]. However, curiously, the Pax half-site in DC5 is dif-
ferent from the high-afﬁnity SELEX (systematic evolution of ligands
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Fig. 2. Complexes of Sox HMGs with partner factors.
(A-F). Topological model of the Sox HMG (blue) bound. The DNA is shown as gray surface and the proteins as backbone ribbons with SoxE and Sox2 in HMG boxes in blue,
Sox17  HMG  in green, Pax6 PRD in orange, Nanog HD in red and bipartite Oct4 POU in red (POU speciﬁc domain, POUS) or brown (POU homeodomain, POUHD) with the
POU  linker in light blue. The sequence of the composite DNA element used to construct the models is shown underneath the structural cartoons. Models depict (A) a SoxE
homodimer on palindromic Sox element with 4 bp spacer with blue HMG  and red DIM [72], (B) Sox2/Pax6 heterodimer model including the Sox2 HMG and the Pax6 paired
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oPRD)  domain on a DC5 element [77], (C) a Sox2/Oct4 heterodimers on an Fgf4 a
ompressed motif [93,94] and (F) a Sox2 HMG/Nanog homeodomain (HD) heterodi
ritical  for the TF partnerships are marked.
y exponential enrichment) identiﬁed PAX consensus [76]. When
he DC5-version of the Pax site is replaced with the SELEX con-
ensus (DC5con) cooperative binding is abolished. This indicated
hat Pax6 binds DNA in two different modes: a high afﬁnity mode
ot compatible with Sox2 cooperation and a high-cooperativity
ode facilitating dimer formation and transactivation. Mutations
f Arg75 of the Sox2 HMG  box diminished complex formation on
C5 suggesting that Arg75 directly mediates the Sox2/Pax6 com-
lex formation [34]. However, when the Sox2 and Pax6 interactionPlease cite this article in press as: L. Hou, et al., Molecular basis for the 
http://dx.doi.org/10.1016/j.semcdb.2016.08.005
n DC5 DNA was probed by NMR, obvious protein interactions could
ot be mapped [77]. This suggests that the Sox2/Pax6 interaction
n DC5 is predominantly driven by a DNA-dependent allosteric) a canonical HoxB1-like elements [34,92,95], (E) Sox17/Oct4 heterodimer on the
n a SELEX-derived composite motif [107,147]. Amino acids discussed in the text as
mode rather than by direct protein–protein interactions (Fig. 2B).
Yet, Arg75 could not be assigned in these experiments. A DNA ele-
ment related to DC5 termed N3 has been found to autoregulate
Sox2 [78]. However, there is no DNA sequence motif describing
functional DC5-like sequences and genome-wide binding studies
have only revealed DNA motifs resembling the SELEX consensus,
albeit this element is present in only small fractions of the total
binding sites [79]. Therefore, for the majority of Pax6 binding sites
it remains unknown which sequence signatures exactly promotegenome engagement by Sox proteins, Semin Cell Dev Biol (2016),
the functional recruitment of Pax6. When sites jointly targeted by
SOX2 and PAX6 in human neural lineages where screened for DC5-
like sites, a number of candidates elements could be identiﬁed [77].
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hus, the cooperation of SOX2 with PAX6 in the eye and neural lin-
ages relies on a cryptic enhancers and indirect mechanisms such
s DNA mediated allostery appear to contribute substantially to
enomic target selection and gene regulation.
.2.2. Sox/Oct
In 1995, Sox2 was found to form a heterodimeric complex
ith Oct4 (also termed Oct3 and encoded by the Pou5f1 gene)
n an element regulating the expression of the Fgf4 gene in the
lastocyst [80]. In the Fgf4 element, Sox and Oct half-sites are
eparated by a 3 bp spacer (CATTGTCnnnATGCAAAT, n denotes
pacer nucleotides) and the precise spacing is important for
gf4 expression [81] (Fig. 2C). Subsequently, functional Sox2/Oct4
eterodimers were found to regulate a number of other genes
ncluding UTF1 [82], Sox2 [83], Nanog [84] and Pou5f1 [85]. How-
ver, in all these genes the half-sites are closer together, and
he 3 bp spacer seen in the Fgf4 element is absent, resulting
n a C1A2T3T4G5T6C7ATGCAAAT-like sequence, which we  hence-
orth term the ‘canonical’ element (Fig. 2D). Strikingly, a canonical
ox/Oct motif was also identiﬁed in genome wide ChIPseq (chro-
atin immunoprecipitation followed by deep sequencing) studies
sing de novo motif discovery tools even if only loci immunopre-
ipitated with Oct4, Nanog, Smad1 or p300 antibodies were taken
nto account [86–89]. Moreover, Sox2 and Oct4 were found to be
ore factors to induce pluripotency in mouse and human somatic
ells in combination with other TFs [24–26] or alone [90,91]. This
uggested that the Sox2/Oct4 heterodimer is of pivotal impor-
ance for the acquisition and maintenance of pluripotency. Based
n the crystal structure of the Sox2 HMG  and the Oct1 POU (Pit-
ct-Unc) domain on the Fgf4 element the molecular basis for the
ox2/Oct4 binding to Fgf4 and Utf1 elements could be modeled and
nalyzed by rational mutagenesis [34]. The molecular picture was
urther clariﬁed by an NMR  structure of a Sox2 HMG/Oct1 POU
imer on HoxB1 DNA [92]. Helix 3 and the ordered C-terminal
ail of the Sox2 HMG  box are the main contributors to direct
rotein–protein interactions during Sox2/Oct4/DNA ternary com-
lex formation (Fig. 2C, D). However, the molecular interfaces and
articipating amino acids mediating the interactions switch on
gf4 and HoxB1-like DNA elements [34]. The POU interface is pro-
ided by the POU-speciﬁc (POUS) part of the bi-partite POU but
ndirect allosteric interaction with the interface-distal POU home-
domain (POUHD) do also contribute to complex formation [93].
nterestingly, some amino acids at the HMG  interface facilitating
OU binding on the canonical element including Glu46 and Lys57
re not conserved amongst Sox paralogs and could mediate Sox-
peciﬁc dimerization proﬁles [94–96]. Indeed, when these amino
cids are mutated, Sox2 is no longer able to cooperate with Oct4
n the canonical motif and looses the ability to induce pluripo-
ency demonstrating that Sox2/Oct4 heterodimers are critical for
his process [94,97,98]. The SoxF factor Sox17 contains an acidic
lutamate at position 57 and only poorly cooperates with Oct4
n canonical motifs. However, when the glutamate is exchanged
ith the basic lysine of Sox2, the engineered Sox17EK protein now
ooperates very effectively with Oct4 on all tested canonical motifs
94,96]. More surprisingly, Sox17EK can also replace wild-type
WT) Sox2 in iPSC generation experiments using somatic mouse
r human cells and even outperforms Sox2 in terms of reprogram-
ing speed and efﬁciency [94,97]. Consistently, ChIPseq analysis
evealed that Sox17EK indeed occupies sites normally bound by
ox2, while WT  Sox17 binds separate locations [99]. Nevertheless,
ox17 also frequently co-binds with Oct4. However, instead of the
anonical sequence, the Sox17/Oct4 dimer is recruited to an alter-Please cite this article in press as: L. Hou, et al., Molecular basis for the 
http://dx.doi.org/10.1016/j.semcdb.2016.08.005
ative C1A2T3T4G5T6ATGCAAAT-like signature sequence (Fig. 2E).
his element differs from the canonical element by the elimina-
ion of nucleotide 7 of the Sox element bordering with the Oct
alf-site and was therefore termed ‘compressed’ DNA motif [94]. PRESS
ental Biology xxx (2016) xxx–xxx
The compressed motif is also enriched in Sox17/Oct4 co-bound
sites in primitive endoderm-like cells [99]. The switch of Sox part-
ners by Oct4 indicates an intimate link between DNA-sequence,
TF–TF co-operation and developmental outcome. WT  Sox2 is not
normally able to dimerize with Oct4 on the compressed motif.
However, replacing residues 46 and 57 with their counterparts in
Sox17 producing a synthetic Sox2E46LK57E protein, installs strong
cooperativity with Oct4 on the compressed motif [95]. Whether this
Sox2 double mutant acquires the Sox17-like capacity of converting
embryonic stem cells (ESCs) into bona ﬁde extraembryonic endo-
derm (XEN) cells remains to be investigated [100]. These studies
suggested a Sox/Oct partner code triggering early developmental
switches. Namely, a Sox2/Oct4 dimer binds the canonical motif to
induce and maintain pluripotency and a Sox17/Oct4 dimer binds
the compressed motif to trigger the differentiation of endodermal
lineages. A number of other synergistically acting Sox/Oct pairs
have been described implying that Sox/Oct dimerization on speciﬁc
composite motifs is a crucial mechanism for context speciﬁc func-
tions of these proteins [22,63]. For example, in neural progenitor
cells (NPCs) Sox2 is thought to switch partners from Oct4 to Brn2
[101]. Early work on Nestin regulation suggested that Sox2/Brn2
partnership is driven by novel conﬁguration of Sox/Oct half-sites
[102]. However, genome-wide studies in NPCs indicated that the
Sox2/Brn2 preferentially forms on canonical motifs albeit on a dif-
ferent subset of canonical motif locations than bound by Sox2/Oct4
in ESCs [101]. Therefore, additional mechanisms must be at play
directing the selection of canonical motifs in these two cell types.
3.2.3. Sox/Nanog
The Nanog TF constitutes one of the hallmark genes of pluripo-
tency alongside Sox2 and Oct4 [103,104]. Nanog binds DNA with a
variant Q50 homeodomain [105] and co-occupies many enhancers
with Sox2 and Oct4 [86,88,89,106]. Co-immunoprecipitation assays
indicated that Nanog and Sox2 robustly interact in ESCs [107]. As
tyrosine residues of the Sox2 serine-rich domain and tryptophan
residues of the Nanog WR repeat are necessary for the interaction,
binding is likely mediated by aromatic stacking. A combined SELEX
for Sox2 and Nanog co-expressed in E.coli revealed an AATnnCATT
composited element with curtailed half-sites compared to the
isolated TAATCG-like and CATTGTC-like consensus sequences for
Nanog or Sox2, respectively [107] (Fig. 2F). This composite motif is
present in a large number of ChIPseq peaks co-bound by Nanog and
Sox2 and it was  suggested that the Sox2/Nanog interaction is more
critical for pluripotency than the Sox2/Oct4 dimer [108]. Possibly,
the Nanog/Sox2 interaction modiﬁes the binding speciﬁcity simi-
larly to the Sox2/Pax6 interaction and relaxes the requirement for
nucleotides ﬂanking the core-binding site. Thus, mutually induced
changes to the binding preferences appear to be a common mecha-
nism for the target gene selection of Sox TFs and their dimerization
partners.
4. High-throughput identiﬁcation of Sox DNA target sites
In 1990, SELEX was developed to comprehensively assess the
binding speciﬁcity of nucleic acid binding proteins [109]. This
technique became soon widely used to construct binding models
for DNA-protein interactions including Sox TFs [29]. Conventional
SELEX is a highly stringent technique providing the highest afﬁnity
binding sites for a given protein. However, in a cellular con-
text, not only the highest afﬁnity consensus sequences but also
the entirety of low and medium binding sites will determinegenome engagement by Sox proteins, Semin Cell Dev Biol (2016),
the genomic binding proﬁle of a TF population. Naturally, all
exposed genomic elements compete for a TF and modify the search
process, that is the time it takes for a given TF to arrive at a func-
tional binding site. Therefore, to predict binding probability from
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equence alone it would be desirable to quantify binding ener-
ies for all kmer/TF interactions. To this end, a high-throughput
ethod termed protein-binding microarrays (PBMs) was devel-
ped capable of probing the binding of large TF sets to 8–10 mer
equences [30,110]. PBM provides a semi-quantitative readout for
he binding of tagged recombinant proteins to microarrays with
sDNA sequences, which is detected using ﬂuorescent antibodies.
ox proteins analyzed by PBM were found to bind a T3T4G5T6 core
equence and which differs from the binding pattern of the Lef/Tcf
amily [30]. Nevertheless, subtle changes in the periphery of this
ore motif allowed the clustering of Sox proteins by their sequence
references although some of the Sox kmer clusters appear to be
istinct only because of changed deﬁnitions of the start site of the
inding site [30]. Moreover, the PBM-derived binding landscape of
any Sox TFs was characterized by a secondary motif. That is, a
osition weight matrix (PWM)  that captures a subset of binding
equences that cannot be satisfactorily described by the primary
WM. For example, the primary motif of mouse Sox4 is C1T2TTGT
nd the secondary motif is A1A2TTGT ([36], uniprobe ID UP00062).
pparently, positions 1 and 2 are interdependent and need to be
hanged concomitantly to maintain a favorable binding energy. The
witch of binding between the motifs appears to be facilitated by a
oordinated conformational change of the side-chains of residues
rg18 and Asn30 [36]. Similar DNA induced changes to the TF con-
ormation have been linked to global conformational switches of
he regulatory complex that inﬂuences co-factor recruitment and
he direction of the regulatory event (activation versus repression)
111]. Yet, it remains controversial whether primary and secondary
otifs represent truly distinctive binding modes [112]. Neverthe-
ess, it is conceivable that changes in the binding sequence of Sox
Fs, such as the primary and secondary motif, modulate the regu-
atory circuitries controlled by these proteins.
High-throughput SELEX (HT-SELEX) combines SELEX with deep
equencing technologies [113]. It can probe longer sequences than
BMs (14–40 base pairs) and is therefore better suited to study
F complexes [114]. Modiﬁcations of HT-SELEX can in principle
e used to derive highly accurate thermodynamic binding mod-
ls [115]. When Sox TFs were studied by HT-SELEX, a head-to-head
seudopalindromic ACAATANC1A2T3T4G5T6 DNA sequences was
btained for many Sox family members [113]. This ﬁnding was
nterpreted as binding of Sox TFs to DNA hairpin structures. As HMG
oxes are long known to recognize unusual DNA structures such as
our-way junctions [55,56] it will be of interest to test if hairpin
inding is of physiological relevance or if it is a technical limitation
f HT-SELEX. Surprisingly, homodimeric binding of Sox HMGs to
ouble-stranded ACAATGNC1A2T3T4G5T6-like sequences was also
bserved recently albeit it is less efﬁcient than binding to more
idely spaced half-sites [72].
. Involvement of domains outside the HMG  box in genome
ngagement
The regions outside of the HMG  box of Sox TFs is largely devoid of
onserved sequences and distinct structural or functional domains
nd has therefore received less attention with few exceptions such
s the SoxE DIM and the coiled-coil of SoxD TFs. The regions outside
he box have well-established roles in transactivation and repres-
ion but its is less clear how they inﬂuence DNA binding and target
ene selection. Structural information of non-HMG regions is at
resent not available. Yet, regions ﬂanking the HMG  box have been
roposed to play critical roles in partner factor interactions andPlease cite this article in press as: L. Hou, et al., Molecular basis for the 
http://dx.doi.org/10.1016/j.semcdb.2016.08.005
elective recognition of genomic loci [69,97,107].
The non-HMG box regions of Sry are very poorly conserved and,
uriously, several other Sox genes could replace Sry to induce XX
ex reversal in mice [116]. In most mammals, Sry is composed PRESS
ental Biology xxx (2016) xxx–xxx 7
of an N-terminal domain (∼30–60 amino acids) and a C-terminal
domain (∼70–100 amino acids) ﬂanking the central HMG  box. In
rat and mouse, however, the N-terminus of Sry is missing and the
C-terminus consists of glutamine repeats interspersed by histidine-
rich segregators. This gave rise to the idea that only the HMG
box of Sry is required for sex determination. However, deﬁcien-
cies in the glutamine-rich C-terminal region failed to confer XX
male sex reversal, implying an important role in male sex deter-
mination [116]. In humans, amino acid substitutions occurring in
the N-terminal domain were detected in patients with XY gonadal
dysgenesis [117,118] some of which were demonstrated to modu-
late DNA binding [119]. Moreover, deleting the non-HMG portion
of Sry reduced binding to the consensus DNA sequence in vitro
[120]. Besides inﬂuencing DNA binding directly, non-HMG box
regions can impact partner factor association thereby modify the
co-targeting of genes by TF complexes analogously to HMG  box
mediated partnerships. For example, a naturally occurring Sox18
ragged allele leads to a C-terminal truncation of the protein but
leaves the HMG  box intact. This deletion compromises the interac-
tion of Sox18 with the MADS-box TF MEF2C [121]. Perturbed dimer
formation, target gene selection and activation could be causative
for the phenotypic consequences of the truncation.
Post-translational modiﬁcations of non-HMG domains present
another mechanism for the regulation of the DNA-binding
activity, transactivation, protein stability and nuclear localiza-
tion of Sox proteins [15,17,122,123]. Several reports indicate
that phosphorylation, sumoylation, glycosylation, acetylation,
O-linked-N-acetylglucosamination (O-GlcNAcylation) and methy-
lation directly inﬂuence DNA recognition by Sox TFs. For example,
phosphorylation of Sox2 primarily at the C-terminal serine-rich
region is a prerequisite for the subsequent sumoylation [124].
Sumoylation of a nearby lysine, in turn, decreases afﬁnity for
Fgf4 DNA and inhibits transcriptional activation [125]. By contrast,
phosphorylation of Sry and Sox9 in the ﬂanks of the HMG  box
has the opposite effect as it increases afﬁnity for DNA [126,127].
O-GlcNAcylation in the C-terminal domain of Sox2 was found to
be a hallmark of pluripotency but the modiﬁcation was read-
ily removed upon differentiation [128]. Possibly, O-GlcNAcylation
contributes to a discrimination of regulatory programs driven by
Sox2 in pluripotent versus somatic cells. Lastly, methylation of
Sox2 by CARM1 at Arg113 enhances the self-association of Sox2
and elevates Sox2-mediated transactivation [129]. Overall, post-
translational modiﬁcations are clearly inﬂuence whether and how
Sox TFs homo and heterodimerize and bind DNA to regulate gene
expression. However, the role of non-HMG box regions on genome
engagement and gene regulation has not yet been systematically
explored so the mechanism of how these modiﬁcations affect
regulatory programs remains largely elusive. As the non-HMG
box regions are the most diverse parts of Sox TFs amongst both
orthologs and paralogs, they are expected to critically impact their
cell type and species-speciﬁc functions.
6. Pioneering activity
Eukaryotic genomes are organized into compacted and open
chromatin regions that stabilize gene expression programs, cel-
lular identities and deter unauthorized cell fate conversions. An
elite subset of TFs such as FoxA1 was suggested to have a unique
ability to directly bind the nucleosomal DNA, to loosen compacted
chromatin and to activate otherwise silenced genes [130–132].
The paradigm pioneer TF FoxA1 has structural similarity to linkergenome engagement by Sox proteins, Semin Cell Dev Biol (2016),
histones and its pioneering activity has been attributed to this sim-
ilarity [133]. However, the TFs Sox2, Oct4 and Klf4 do not resemble
linker histones but were recently shown to effectively bind nucleo-
some wrapped DNA in vitro and to associate with closed chromatin
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t early stages of iPSC generation [134,135]. The authors performed
e novo motif analysis for Sox2, Oct4 and Klf4 binding sites in
ucleosome free versus nucleosome bound loci as distinguished
sing MNase-seq data (micrococcal nuclease digestion followed
y deep sequencing). All three TFs bound their canonical motifs in
ucleosome-free loci but bound to degenerate or partial motifs in
ucleosome wrapped regions. In the case of Sox2, the 5th position
f the CTTTG5T degenerated to a CTTTN5T version. Notably, muta-
ions of the G at the 5th position were shown to profoundly reduce
NA bending upon Sox2 binding using circular permutations assays
56]. Given the smooth curvature of nucleosome bound DNA, the
ack of a conserved G at position 5 has been interpreted to better
ccommodate Sox2 binding to nucleosomal DNA as a strong bend
s neither possible nor necessary in the context of the nucleosome
135]. Thus, the ability of Sox2 to bind and only moderately bend
NA with a degenerate Sox motif on nucleosome surfaces has been
uggested to be a key driver for its pioneering activity.
Interestingly, a single molecule tracking study in live ESCs
emonstrated that Sox2 reduced the search time of Oct4 to cog-
ate binding sites and increased the residence time of Oct4 [136].
onversely, Oct4 did not shorten the search of Sox2 but moder-
tely increased residence time. This suggested that Sox2 binds ﬁrst
o cognate Sox/Oct DNA elements and subsequently recruits Oct4.
he resulting Sox2/Oct4/DNA ternary complex is overall more sta-
le than the individual binary complexes [136]. The single molecule
ssays did not distinguish between binding to free DNA or nucleo-
omal DNA leaving open whether the hierarchy of binding is similar
n either context.
In a different study, Sox as wells as Lef/Tcf TFs were classiﬁed
s ‘migrant TFs’ in an effort to probe the ability of TFs to open up
hromatin as measured by dynamic changes of DNase I hypersensi-
ivity footprint sites during the differentiation of ESCs to endoderm
137]. By this deﬁnition, migrants TFs, in contrast to pioneer TFs,
annot open up chromatin by themselves and rely on additional
timuli such as co-factors to select their cognate target sites in open
hromatin. Collectively, the pioneering function of Sox TFs leaves
everal open questions and further work is needed to unify the var-
ous experimental approaches into a common picture. In principle,
he shared features of Sox TFs with nsHMGs that include archi-
ectural components of chromatin and subunits of the chromatin
oosening FACT complex appear to qualify them as potent pioneers.
ossibly, Sox TFs concomitantly function to direct transcriptional
egulation as well as to reorganize chromatin, which is necessary
or cellular reprogramming.
. Perspectives
Since their discovery more than a quarter of a century ago, Sox
Fs captivate an ever increasing community of researchers for their
eculiar mode of DNA binding, their ability to pioneer cell fate con-
ersions and the staggeringly vast array of cellular identities they
etermine. In addition to the topics discussed here, unexpected
ovel themes are emerging such as the interplay of Sox proteins
nd RNAs. In 2001, it was found that Sry and Sox6 co-localize with
plicing factors in nucleus and modulate intron selection in vitro via
heir HMG box [138]. More recently, a direct cooperation between
he long non-coding RNA RMST and Sox2 was found to inﬂuence
arget gene selection by Sox2 and to regulate neurogenesis [139].
ell-established partner factors directing cell-type speciﬁc func-
ions of TFs such as Pax and Oct TFs may  just represent the tip of the
ceberg. Otx2 and Esrrb have also been reported to team up withPlease cite this article in press as: L. Hou, et al., Molecular basis for the 
http://dx.doi.org/10.1016/j.semcdb.2016.08.005
ox2 in the eye or in epiblast stem cells [140–142]. In addition, an
xtension of HT-SELEX to obtain dimer elements recovered a num-
er of co-motifs of Sox factors with, for example, Tead4 and Meis1
114]. Finally, it was suggested that the engineering of synthetic PRESS
ental Biology xxx (2016) xxx–xxx
TFs has a great potential to more effectively drive cell fate conver-
sions to produce cells for regenerative biomedicine [143–146]. It is
thus of interest to explore the utility of synthetic Sox TFs, such as
Sox17EK, for mammalian synthetic biology and the production of
functional ‘transplantation ready’ cells.
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